Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_52223 | 30 | 0.62 | Mlig455_029799 | Neo: - Age: - |
GLRA2 | Mlig455_029799 {REF} {Length: 3197} {tRNA: Val(CAC),pseudo, score=27.6} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=122.6]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=350, Expect=1e-116]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=4e-115]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=3e-112]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=345, Expect=3e-115]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=2e-113]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=337, Expect=9e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=334, Expect=1e-110]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=8e-98]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [RH, Score=274, Expect=3e-88]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=265, Expect=1e-84]} {RNA1509_44790} {RNA1310_18585} {RNA815_38424} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.103 | 1.12 | 0.99976 | 1.00000 | |
RegionR2 | 1.955 | 1.12 | 0.93582 | 1.00000 | |
RegionR3 | -2.63 | 1.12 | 0.99963 | 1.00000 | |
RegionR4 | 3.112 | 1.12 | 0.10825 | 0.32415 | |
RegionR5 | -0.071 | 1.12 | 0.74969 | 1.00000 | |
RegionR6 | 0.034 | 1.12 | 0.95066 | 1.00000 | |
RegionR7 | -1.83 | 1.12 | 1.00000 | 1.00000 | |
RegionR8 | -1.673 | 1.12 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.287 | 1.12 | 0.99984 | 1.00000 | |
RegenerationR2 | 0.379 | 1.12 | 0.73058 | 0.96572 | |
RegenerationR3 | 4.118 | 1.12 | 0.34543 | 0.76876 | |
RegenerationR4 | -1.178 | 1.12 | 0.30896 | 0.74957 | |
RegenerationR5 | 0.223 | 1.12 | 0.67797 | 0.94359 | |
RegenerationR6 | -1.103 | 1.12 | 0.60274 | 0.86997 | |
RegenerationBL | -1.069 | 1.12 | 0.99971 | 1.00000 | |
RegenerationTP | -0.817 | 1.12 | 0.99977 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_52223 | 30 | 0.62 | Mlig455_029799 | Neo: - Age: - |
GLRA2 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_029799 {REF} {Length: 3197} {tRNA: Val(CAC),pseudo, score=27.6} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=122.6]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=350, Expect=1e-116]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=4e-115]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=3e-112]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=345, Expect=3e-115]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=2e-113]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=337, Expect=9e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=334, Expect=1e-110]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=8e-98]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [RH, Score=274, Expect=3e-88]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=265, Expect=1e-84]} {RNA1509_44790} {RNA1310_18585} {RNA815_38424} |
2. | MligTC455_17003 | 32 | 0.66 | Mlig455_011034 | Neo: - |
P2RX2 | 1.883 | - | - | 0.974 | - | - | 0.909 | Mlig455_011034 {REF} {Length: 2894} {Pfam: ATP P2X receptor [PF00864.21, score=288.1]} {Human: ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=206, Expect=3e-60]; ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=201, Expect=7e-59]} {Mouse: ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=202, Expect=8e-59]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=269, Expect=3e-84]} {RNA1509_56054} {RNA1310_31414} {RNA815_43099} |
3. | MligTC455_12824 | 21 | 0.44 | Mlig455_015782, Mlig455_045748 | Neo: - Age: - |
NPY1R | 1.868 | - | - | - | - | 0.914 | 0.954 | Mlig455_015782 {REF} {Length: 771} {NoTransDecoderORF} {RNA1310_145549} Mlig455_045748 {REF} {Length: 3703} {tRNA: Val(CAC),pseudo, score=23.6} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=128.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.1]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=125, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=124, Expect=3e-31]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=123, Expect=4e-31]; ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=119, Expect=2e-29]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=161, Expect=2e-44]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=137, Expect=4e-36]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=228, Expect=7e-70]} {RNA1509_45595} {RNA1310_56759} {RNA815_43101} |
4. | MligTC455_29874 | 65 | 1.36 | Mlig455_037947, Mlig455_068699 | Neo: - Age: logFC(26M/2M)=-0.467 |
ANKRD50 | 1.848 | - | - | - | - | 0.955 | 0.893 | Mlig455_037947 {REF} {Length: 4099} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=309.9]; Ankyrin repeat [PF00023.32, score=295.0]; Ankyrin repeat [PF13606.8, score=230.6]; Ankyrin repeats (many copies) [PF13637.8, score=228.6]; Ankyrin repeats (many copies) [PF13857.8, score=200.7]; Glutamine amidotransferase domain [PF13537.8, score=68.9]; PEGA domain [PF08308.13, score=35.0]; Mab-21 protein [PF03281.16, score=29.5]; Nucleoplasmin/nucleophosmin domain [PF03066.17, score=26.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=276, Expect=2e-75]; ENSG00000029534, ANK1, ankyrin 1, [Score=270, Expect=5e-73]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=274, Expect=8e-75]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=256, Expect=7e-69]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=258, Expect=1e-69]} {Smed: dd_Smed_v6_2072_0_29, dd_Smed_v6_2072_0_29, [Score=256, Expect=2e-71]} {RNA1509_26004, RNA1509_28959} {RNA1310_3906.1, RNA1509_28959} {RNA1509_28959, RNA815_1664.1} Mlig455_068699 {REF} {Length: 2234} {Pfam: Mab-21 protein [PF03281.16, score=31.1]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
5. | MligTC455_36971 | 10 | 0.21 | Mlig455_059331 | Neo: - Age: logFC(26M/2M)=-0.386 |
KIF9 | 1.836 | - | - | 0.955 | - | - | 0.881 | Mlig455_059331 {REF} {Length: 3095} {TRANSSPLICED} {Pfam: Kinesin motor domain [PF00225.25, score=306.7]; Microtubule binding [PF16796.7, score=68.3]} {Human: ENSG00000088727, KIF9, kinesin family member 9, [RH, Score=606, Expect=0.0]} {Mouse: ENSMUSG00000032489, Kif9, kinesin family member 9, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0004380, Klp64D, Kinesin-like protein at 64D, [Score=211, Expect=2e-57]} {Celegans: WBGene00003884, osm-3, Osmotic avoidance abnormal protein 3, [Score=220, Expect=1e-60]} {Smed: dd_Smed_v6_6755_0_1, dd_Smed_v6_6755_0_1, [RH, Score=761, Expect=0.0]} {RNA1509_1683} {RNA1310_5586.1} {RNA815_1778.1} |
6. | MligTC455_13456 | 43 | 0.89 | Mlig455_065240 | Neo: - Age: - |
ARRDC3 | 1.82 | - | - | 0.950 | - | 0.870 | - | Mlig455_065240 {REF} {Length: 1385} {TRANSSPLICED} {Pfam: Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=64.6]; Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=54.7]} {Human: ENSG00000113369, ARRDC3, arrestin domain containing 3, [Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000074794, Arrdc3, arrestin domain containing 3, [Score=81.6, Expect=1e-17]} {Dmel: FBgn0037465, CG1105, [Score=95.5, Expect=1e-22]} {Celegans: WBGene00012467, arrd-8, ARRestin Domain protein, [Score=83.6, Expect=9e-19]} {RNA1310_40788} {RNA815_61509} |
7. | MligTC455_38419 | 298 | 6.22 | Mlig455_055922 | Neo: - Age: - |
1.798 | - | - | - | - | 0.848 | 0.950 | Mlig455_055922 {REF} {Length: 1428} {RNA1509_21831} {RNA1310_22461, RNA1509_21831} {RNA1509_21831, RNA815_11600} | |
8. | MligTC455_52036 | 13 | 0.27 | Mlig455_068246, Mlig455_068266 | Neo: - Age: - |
1.787 | - | - | 0.952 | - | 0.835 | - | Mlig455_068246 {REF} {Length: 593} {NoTransDecoderORF} {RNA1509_46135} {RNA1310_32009.2} Mlig455_068266 {REF} {Length: 787} {NoTransDecoderORF} {RNA1509_46135} {RNA1310_32009.2} |
|
9. | MligTC455_01727 | 6 | 0.14 | Mlig455_034612 | Neo: - Age: - |
1.763 | - | - | 0.955 | - | 0.808 | - | Mlig455_034612 {REF} {Length: 1062} {Pfam: Interferon-induced transmembrane protein [PF04505.14, score=24.1]} {RNA1310_112233} | |
10. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 1.76 | - | - | 0.803 | - | 0.957 | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
11. | MligTC455_25197 | 36 | 0.74 | Mlig455_059562 | Neo: - Age: - |
KY | 1.741 | - | - | - | 0.750 | 0.991 | - | Mlig455_059562 {REF} {Length: 5559} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=79.0, Expect=2e-14]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=68.2, Expect=3e-11]} {Smed: dd_Smed_v6_1109_0_1, dd_Smed_v6_1109_0_1, [Score=100, Expect=5e-21]} {RNA1509_6021} {RNA1310_875.1} {RNA815_349} |
12. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 1.74 | - | - | - | - | 0.950 | 0.790 | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
13. | MligTC455_51603 | 39 | 0.81 | Mlig455_016769 | Neo: - Age: - |
1.733 | - | - | 0.771 | 0.962 | - | - | Mlig455_016769 {REF} {Length: 1577} {RNA1509_44500} {RNA1310_22352} {RNA815_21481} | |
14. | MligTC455_24534 | 14 | 0.29 | Mlig455_011965 | Neo: - Age: - |
1.703 | - | - | 0.968 | - | 0.735 | - | Mlig455_011965 {REF} {Length: 1288} {NoTransDecoderORF} {RNA1509_28752} {RNA1310_137924} {RNA815_7756.1} | |
15. | MligTC455_08277 | 39 | 0.81 | Mlig455_015604 | Neo: - Age: - |
PAQR8 | 1.669 | - | - | - | - | 0.708 | 0.961 | Mlig455_015604 {REF} {Length: 1803} {Pfam: Haemolysin-III related [PF03006.22, score=71.6]} {Human: ENSG00000170915, PAQR8, progestin and adipoQ receptor family member 8, [Score=82.0, Expect=8e-17]} {Mouse: ENSMUSG00000025931, Paqr8, progestin and adipoQ receptor family member VIII, [Score=86.3, Expect=2e-18]} {Dmel: FBgn0038256, CG7530, [Score=50.8, Expect=7e-07]} {Celegans: WBGene00019643, K11C4.2, [Score=62.8, Expect=6e-11]} {Smed: dd_Smed_v6_14141_0_1, dd_Smed_v6_14141_0_1, [Score=65.5, Expect=9e-12]} {RNA1509_10181} {RNA1310_17206} {RNA815_6661} |
16. | MligTC455_38049 | 11 | 0.23 | Mlig455_051337 | Neo: - Age: - |
0.995 | - | - | 0.995 | - | - | - | Mlig455_051337 {REF} {Length: 2246} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=25.9]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=49.3, Expect=5e-07]} {RNA1310_57034} {RNA815_35311} | |
17. | MligTC455_37350 | 54 | 1.12 | Mlig455_052436 | Neo: - Age: - |
0.992 | - | - | 0.992 | - | - | - | Mlig455_052436 {REF} {Length: 3228} {Pfam: PHD-finger [PF00628.31, score=24.5]} {RNA1509_53488} {RNA1310_40766} | |
18. | MligTC455_49907 | 79 | 1.65 | Mlig455_059454 | Neo: - Age: Up-Down-Down |
0.982 | - | - | - | - | 0.982 | - | Mlig455_059454 {REF} {Length: 2213} {Pfam: Otopetrin [PF03189.15, score=92.9]} {Dmel: FBgn0259994, CG42492, [Score=79.3, Expect=3e-16]} {Celegans: WBGene00018478, otpl-5, OToPetrin-Like, [Score=75.5, Expect=3e-15]} {Smed: dd_Smed_v6_15458_0_1, dd_Smed_v6_15458_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_31431.1} {RNA815_29709} | |
19. | MligTC455_38748 | 58 | 1.21 | Mlig455_061816 | Neo: - Age: - |
0.978 | - | - | - | - | - | 0.978 | Mlig455_061816 {REF} {Length: 1047} {RNA1509_29037} {RNA1310_1430.1} {RNA815_36259} | |
20. | MligTC455_39860 | 56 | 1.17 | Mlig455_046932 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_046932 {REF} {Length: 920} {RNA1310_30968} {RNA815_45889} | |
21. | MligTC455_13741 | 6 | 0.12 | Mlig455_062833 | Neo: - Age: Down-Up-Down |
GLUL | 0.975 | - | - | 0.975 | - | - | - | Mlig455_062833 {REF} {Length: 3461} {Pfam: Glutamine synthetase, beta-Grasp domain [PF03951.21, score=49.3]; Glutamine synthetase, catalytic domain [PF00120.26, score=46.0]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=519, Expect=0.0]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=522, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=529, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=530, Expect=0.0]} {Smed: dd_Smed_v6_646_0_1, dd_Smed_v6_646_0_1, [RH, Score=573, Expect=0.0]} {RNA1509_3029} {RNA1310_32301} |
22. | MligTC455_32900 | 52 | 1.08 | Mlig455_050893 | Neo: - Age: logFC(26M/2M)=0.368 |
CA7 | 0.975 | - | - | 0.975 | - | - | - | Mlig455_050893 {REF} {Length: 4828} {Pfam: Eukaryotic-type carbonic anhydrase [PF00194.23, score=224.5]} {Human: ENSG00000168748, CA7, carbonic anhydrase 7, [Score=201, Expect=6e-64]} {Mouse: ENSMUSG00000031883, Car7, carbonic anhydrase 7, [Score=196, Expect=2e-62]} {Dmel: FBgn0027844, CAH1, Carbonic anhydrase 1, [Score=176, Expect=2e-54]} {Celegans: WBGene00000281, cah-3, Putative carbonic anhydrase 3, [Score=135, Expect=8e-39]} {Smed: dd_Smed_v6_5784_0_1, dd_Smed_v6_5784_0_1, [Score=184, Expect=7e-58]} {RNA1509_23444} {RNA1310_23047.1} {RNA815_11571.2} |
23. | MligTC455_14033 | 19 | 0.39 | Mlig455_060854 | Neo: - Age: - |
0.974 | - | - | 0.974 | - | - | - | Mlig455_060854 {REF} {Length: 2028} {RNA1509_3734} {RNA1310_43722.2} {RNA815_21450.2} | |
24. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
25. | MligTC455_31150 | 21 | 0.44 | Mlig455_019495 | Neo: - Age: - |
0.973 | - | - | 0.973 | - | - | - | Mlig455_019495 {REF} {Length: 1330} {NoTransDecoderORF} {RNA1310_136064} {RNA815_40041} | |
26. | MligTC455_53469 | 147 | 3.06 | Mlig455_041643, Mlig455_041757 | Neo: - Age: - |
SLC4A11 | 0.973 | - | - | 0.973 | - | - | - | Mlig455_041643 {REF} {Length: 3673} {Pfam: HCO3- transporter family [PF00955.23, score=539.9]; Band 3 cytoplasmic domain [PF07565.15, score=26.9]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=18.8]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=569, Expect=0.0]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0036043, CG8177, [Score=249, Expect=4e-69]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=684, Expect=0.0]} {Smed: dd_Smed_v6_12290_0_1, dd_Smed_v6_12290_0_1, [RH, Score=942, Expect=0.0]} {RNA1509_30019} {RNA1310_3829.1, RNA1509_30019} {RNA1509_30019, RNA815_21278} Mlig455_041757 {REF} {Length: 3365} {Pfam: HCO3- transporter family [PF00955.23, score=539.9]; Band 3 cytoplasmic domain [PF07565.15, score=27.1]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=19.0]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=568, Expect=0.0]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=556, Expect=0.0]} {Dmel: FBgn0036043, CG8177, [Score=247, Expect=9e-69]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=683, Expect=0.0]} {Smed: dd_Smed_v6_12290_0_1, dd_Smed_v6_12290_0_1, [RH, Score=941, Expect=0.0]} {RNA1509_30019} {RNA1310_3829.1} {RNA815_21278} |
27. | MligTC455_27580 | 33 | 0.7 | Mlig455_006429 | Neo: - Age: Up-Down-Up |
CRB2 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_006429 {REF} {Length: 5937} {TRANSSPLICED} {Pfam: EGF-like domain [PF00008.29, score=162.2]; Human growth factor-like EGF [PF12661.9, score=76.7]; Laminin G domain [PF02210.26, score=31.2]} {Human: ENSG00000148204, CRB2, crumbs 2, cell polarity complex component, [Score=344, Expect=2e-99]; ENSG00000148400, NOTCH1, notch 1, [Score=327, Expect=1e-91]} {Mouse: ENSMUSG00000035403, Crb2, crumbs family member 2, [Score=337, Expect=1e-96]} {Dmel: FBgn0259685, crb, crumbs, [Score=428, Expect=1e-125]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=241, Expect=3e-64]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=243, Expect=2e-65]} {RNA1509_32484} {RNA1310_6715.1} {RNA815_693.1} |
28. | MligTC455_22837 | 484 | 10.08 | Mlig455_005509, Mlig455_006648, Mlig455_006694, Mlig455_010631, Mlig455_023501, Mlig455_030951, Mlig455_032677 | Neo: - Age: Up-Down-Up |
0.969 | - | - | - | - | 0.969 | - | Mlig455_005509 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_006648 {REF} {Length: 2757} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_006694 {REF} {Length: 1368} {RNA1310_105426} {RNA815_46313} Mlig455_010631 {REF} {Length: 1245} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_023501 {REF} {Length: 1139} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_030951 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} Mlig455_032677 {REF} {Length: 1003} {TRANSSPLICED} {RNA1509_13897} {RNA1310_19938.1} {RNA815_11593} |
|
29. | MligTC455_13079 | 125 | 2.61 | Mlig455_007628, Mlig455_020961 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_007628 {REF} {Length: 1164} {RNA1509_16706} {RNA1310_88024} {RNA815_39833} Mlig455_020961 {REF} {Length: 1442} {NoTransDecoderORF} {RNA1310_88024} {RNA815_39833} |
|
30. | MligTC455_13258 | 51 | 1.07 | Mlig455_006014, Mlig455_066582 | Neo: Int S/G2/M Age: - |
0.966 | - | - | - | - | - | 0.966 | Mlig455_006014 {REF} {Length: 1250} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=36.0]} {Smed: dd_Smed_v6_71482_0_1, dd_Smed_v6_71482_0_1, [RH, Score=67.0, Expect=2e-13]} {RNA1310_41523} {RNA815_38667} Mlig455_066582 {REF} {Length: 921} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=38.1]} {Dmel: FBgn0030617, CG9095, [Score=44.3, Expect=7e-06]} {Smed: dd_Smed_v6_71482_0_1, dd_Smed_v6_71482_0_1, [Score=62.8, Expect=4e-13]} {RNA1310_41523} {RNA815_38667} |
|
31. | MligTC455_28820 | 112 | 2.33 | Mlig455_043688, Mlig455_047470 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 5.443/0.00566 |
SNIP1 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_043688 {REF} {Length: 1694} {TRANSSPLICED} {Pfam: FHA domain [PF00498.28, score=63.4]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=28.1]} {Human: ENSG00000163877, SNIP1, Smad nuclear interacting protein 1, [RH, Score=233, Expect=4e-73]} {Mouse: ENSMUSG00000050213, Snip1, Smad nuclear interacting protein 1, [RH, Score=229, Expect=5e-72]} {Dmel: FBgn0039943, CG17168, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00016323, C32E8.5, [RH, Score=219, Expect=2e-69]} {Smed: dd_Smed_v6_13351_0_1, dd_Smed_v6_13351_0_1, [RH, Score=108, Expect=6e-29]} {RNA1509_52645} {RNA1310_26855.2} {RNA815_15090} Mlig455_047470 {REF} {Length: 1634} {TRANSSPLICED} {Pfam: FHA domain [PF00498.28, score=63.4]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=28.1]} {Human: ENSG00000163877, SNIP1, Smad nuclear interacting protein 1, [RH, Score=230, Expect=2e-72]} {Mouse: ENSMUSG00000050213, Snip1, Smad nuclear interacting protein 1, [RH, Score=229, Expect=2e-72]} {Dmel: FBgn0039943, CG17168, [RH, Score=233, Expect=2e-73]} {Celegans: WBGene00016323, C32E8.5, [RH, Score=219, Expect=1e-69]} {Smed: dd_Smed_v6_13351_0_1, dd_Smed_v6_13351_0_1, [RH, Score=108, Expect=5e-29]} {RNA1509_52645} {RNA1310_26855.2, RNA1509_52645} {RNA1509_52645, RNA815_15090} |
32. | MligTC455_29913 | 199 | 4.14 | Mlig455_027712, Mlig455_027722, Mlig455_027913 | Neo: - Age: - |
ANK1, ANKRD36B | 0.966 | - | - | - | - | - | 0.966 | Mlig455_027712 {REF} {Length: 1717} {RNA1509_21341} {RNA1310_7057.1} {RNA815_12060.1} Mlig455_027722 {REF} {Length: 2267} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=67.4]; Ankyrin repeats (many copies) [PF13637.8, score=46.0]; Ankyrin repeats (many copies) [PF13857.8, score=32.7]; Ankyrin repeat [PF13606.8, score=27.7]; Ankyrin repeat [PF00023.32, score=22.3]} {Human: ENSG00000196912, ANKRD36B, ankyrin repeat domain 36B, [Score=66.2, Expect=2e-11]; ENSG00000106013, ANKRD7, ankyrin repeat domain 7, [Score=65.9, Expect=3e-11]; ENSG00000163046, ANKRD30BL, ankyrin repeat domain 30B like, [Score=65.5, Expect=4e-11]; ENSG00000180777, ANKRD30B, ankyrin repeat domain 30B, [Score=63.9, Expect=6e-10]} {Mouse: ENSMUSG00000029517, Ankrd7, ankyrin repeat domain 7, [Score=65.5, Expect=3e-11]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=63.2, Expect=3e-10]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=63.2, Expect=3e-10]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=62.4, Expect=1e-09]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=55.8, Expect=1e-07]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=54.7, Expect=2e-07]} {Smed: dd_Smed_v6_1432_0_3, dd_Smed_v6_1432_0_3, [Score=60.8, Expect=2e-09]} {RNA1509_21341} {RNA1310_7057.1} {RNA815_12060.1} Mlig455_027913 {REF} {Length: 2198} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=37.7]; Ankyrin repeats (3 copies) [PF12796.9, score=33.6]; Ankyrin repeat [PF13606.8, score=28.5]; Ankyrin repeats (many copies) [PF13637.8, score=25.8]; Ankyrin repeat [PF00023.32, score=24.7]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=48.1, Expect=2e-07]; ENSG00000134313, KIDINS220, kinase D interacting substrate 220, [Score=45.8, Expect=1e-06]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=49.7, Expect=4e-08]} {Dmel: FBgn0027596, Kank, [Score=48.5, Expect=8e-08]} {Smed: dd_Smed_v6_29517_0_1, dd_Smed_v6_29517_0_1, [Score=45.1, Expect=8e-07]} {RNA1509_21341} {RNA1310_7057.2} {RNA815_12060.1} |
33. | MligTC455_50649 | 91 | 1.9 | Mlig455_014003 | Neo: - |
GRM3 | 0.964 | - | - | - | 0.964 | - | - | Mlig455_014003 {REF} {Length: 4598} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=148.4]; Receptor family ligand binding region [PF01094.30, score=25.5]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=23.6]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [Score=243, Expect=1e-68]; ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [Score=235, Expect=1e-65]; ENSG00000164082, GRM2, glutamate metabotropic receptor 2, [Score=233, Expect=3e-65]; ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [Score=231, Expect=2e-64]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [Score=240, Expect=7e-68]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [Score=237, Expect=1e-66]; ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [Score=236, Expect=3e-66]; ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [Score=234, Expect=9e-66]} {Dmel: FBgn0050361, mtt, mangetout, [Score=273, Expect=2e-80]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [Score=213, Expect=1e-58]} {Smed: dd_Smed_v6_10130_0_1, dd_Smed_v6_10130_0_1, [Score=290, Expect=1e-85]} {RNA1509_34817} {RNA1310_58007} {RNA815_44956} |
34. | MligTC455_52935 | 29 | 0.61 | Mlig455_014479 | Neo: - Age: - |
PROX1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_014479 {REF} {Length: 1320} {Pfam: Homeo-prospero domain [PF05044.14, score=192.8]} {Human: ENSG00000117707, PROX1, prospero homeobox 1, [Score=163, Expect=5e-44]; ENSG00000119608, PROX2, prospero homeobox 2, [Score=159, Expect=4e-43]} {Mouse: ENSMUSG00000010175, Prox1, prospero homeobox 1, [Score=163, Expect=4e-44]; ENSMUSG00000042320, Prox2, prospero homeobox 2, [Score=162, Expect=2e-44]} {Dmel: FBgn0004595, pros, prospero, [Score=182, Expect=1e-50]} {Celegans: WBGene00000448, pros-1, Homeobox protein prospero homolog 1, [Score=178, Expect=1e-50]} {Smed: dd_Smed_v6_48508_0_1, dd_Smed_v6_48508_0_1, [Score=165, Expect=9e-50]} {RNA1310_102283} |
35. | MligTC455_06757 | 20 | 0.41 | Mlig455_022390 | Neo: - Age: - |
WSCD2 | 0.961 | - | - | - | - | - | 0.961 | Mlig455_022390 {REF} {Length: 1688} {Pfam: WSC domain [PF01822.21, score=51.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=58.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=49.7, Expect=2e-06]} {RNA1310_82669} {RNA815_55391} |
36. | MligTC455_13734 | 19 | 0.4 | Mlig455_066088 | Neo: - Age: Down-Up-Down |
0.961 | - | - | - | - | 0.961 | - | Mlig455_066088 {REF} {Length: 1207} {RNA1310_47485} {RNA815_44269} | |
37. | MligTC455_23024 | 42 | 0.88 | Mlig455_064155 | Neo: Int S/G2/M Age: - |
PRR9 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_064155 {REF} {Length: 2553} {Human: ENSG00000203783, PRR9, proline rich 9, [RH, Score=53.5, Expect=2e-08]} {Celegans: WBGene00018026, F35A5.4, [Score=80.9, Expect=1e-16]} {RNA1509_48555} {RNA1310_11521.2} {RNA815_6905.1} |
38. | MligTC455_31436 | 45 | 0.93 | Mlig455_051603 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_051603 {REF} {Length: 2012} {Pfam: Transposase protein [PF12017.10, score=26.8]} {RNA1509_42786} {RNA1310_18602.1} {RNA815_23925} | |
39. | MligTC455_32928 | 79 | 1.65 | Mlig455_016813 | Neo: - |
PPIP5K1 | 0.958 | - | - | 0.958 | - | - | - | Mlig455_016813 {REF} {Length: 5457} {Pfam: Histidine phosphatase superfamily (branch 2) [PF00328.24, score=356.4]; Diphosphoinositol pentakisphosphate kinase 2 N-terminal domain [PF18086.3, score=126.5]} {Human: ENSG00000168781, PPIP5K1, diphosphoinositol pentakisphosphate kinase 1, [RH, Score=987, Expect=0.0]; ENSG00000145725, PPIP5K2, diphosphoinositol pentakisphosphate kinase 2, [RH, Score=972, Expect=0.0]} {Mouse: ENSMUSG00000040648, Ppip5k2, diphosphoinositol pentakisphosphate kinase 2, [RH, Score=976, Expect=0.0]; ENSMUSG00000033526, Ppip5k1, diphosphoinositol pentakisphosphate kinase 1, [RH, Score=958, Expect=0.0]} {Dmel: FBgn0027279, l(1)G0196, lethal (1) G0196, [RH, Score=998, Expect=0.0]} {Celegans: WBGene00018508, F46F11.1, Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase, [RH, Score=843, Expect=0.0]} {Smed: dd_Smed_v6_7203_0_1, dd_Smed_v6_7203_0_1, [RH, Score=1011, Expect=0.0]} {RNA1509_45082, RNA1509_5603} {RNA1310_1762, RNA1509_45082} {RNA1509_45082, RNA815_457} |
40. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
41. | MligTC455_25414 | 32 | 0.66 | Mlig455_000371 | Neo: - |
TRPM3 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_000371 {REF} {Length: 4372} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=75.7]; Ankyrin repeats (many copies) [PF13637.8, score=64.1]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeats (many copies) [PF13857.8, score=31.8]; Ankyrin repeat [PF00023.32, score=27.0]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=79.3, Expect=3e-14]; ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=76.6, Expect=2e-13]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=64.7, Expect=4e-10]} {Smed: dd_Smed_v6_26251_0_1, dd_Smed_v6_26251_0_1, [Score=79.3, Expect=8e-15]} {RNA1509_18305} {RNA1310_1324.1} {RNA815_16630} |
42. | MligTC455_43950 | 2296 | 47.84 | Mlig455_029261, Mlig455_035647, Mlig455_035748 | Neo: - Age: - Regeneration-downregulated BL: -2.094 Regeneration-depleted BL: -2.094 |
0.957 | - | - | - | - | 0.957 | - | Mlig455_029261 {REF} {Length: 2798} {RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1310_10383, RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1509_28538, RNA1509_39513, RNA1509_9241, RNA815_3519} Mlig455_035647 {REF} {Length: 2505} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} Mlig455_035748 {REF} {Length: 2496} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} |
|
43. | MligTC455_40841 | 16 | 0.34 | Mlig455_003915, Mlig455_022710 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_003915 {REF} {Length: 3963} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.6]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=64.3, Expect=1e-10]} {Smed: dd_Smed_v6_9790_0_1, dd_Smed_v6_9790_0_1, [Score=196, Expect=2e-55]} {RNA1509_1108} {RNA1310_105330} {RNA815_1603} Mlig455_022710 {REF} {Length: 2064} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=69.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=42.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.0]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=59.7, Expect=2e-09]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=71.2, Expect=4e-13]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=54.7, Expect=6e-08]} {Smed: dd_Smed_v6_14651_0_1, dd_Smed_v6_14651_0_1, [RH, Score=161, Expect=9e-46]} {RNA1509_10628} {RNA1310_9160} {RNA815_10117.1} |
|
44. | MligTC455_50684 | 144 | 3.01 | Mlig455_008825 | Neo: - Age: Up-Down-Down |
0.956 | - | - | - | - | - | 0.956 | Mlig455_008825 {REF} {Length: 1594} {RNA1509_24338} {RNA1310_77.2} {RNA815_489} | |
45. | MligTC455_15876 | 14 | 0.29 | Mlig455_030439 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_030439 {REF} {Length: 1373} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.8]} {Smed: dd_Smed_v6_45517_0_1, dd_Smed_v6_45517_0_1, [Score=71.2, Expect=5e-14]} | |
46. | MligTC455_19539 | 30 | 0.63 | Mlig455_011109 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_011109 {REF} {Length: 1837} {RNA1310_36241} | |
47. | MligTC455_37760 | 15 | 0.3 | Mlig455_014788 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_014788 {REF} {Length: 2694} {Pfam: CUB domain [PF00431.22, score=48.3]} {RNA1310_77188} | |
48. | MligTC455_40635 | 33 | 0.7 | Mlig455_046793 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.198 Region-enriched R2: 8.074/0.00225 |
CORO1B | 0.955 | - | - | 0.955 | - | - | - | Mlig455_046793 {REF} {Length: 2396} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF1899) [PF08953.13, score=89.7]; Type of WD40 repeat [PF16300.7, score=62.5]; WD domain, G-beta repeat [PF00400.34, score=35.4]} {Human: ENSG00000172725, CORO1B, coronin 1B, [Score=386, Expect=4e-129]; ENSG00000110880, CORO1C, coronin 1C, [Score=381, Expect=2e-127]; ENSG00000167549, CORO6, coronin 6, [Score=380, Expect=4e-127]; ENSG00000102879, CORO1A, coronin 1A, [Score=379, Expect=1e-126]} {Mouse: ENSMUSG00000097771, Coro1b, coronin, actin binding protein 1B, [Score=392, Expect=1e-131]; ENSMUSG00000024835, Coro1b, coronin, actin binding protein 1B, [Score=392, Expect=1e-131]; ENSMUSG00000030707, Coro1a, coronin, actin binding protein 1A, [Score=385, Expect=5e-129]; ENSMUSG00000004530, Coro1c, coronin, actin binding protein 1C, [Score=381, Expect=2e-127]; ENSMUSG00000020836, Coro6, coronin 6, [Score=377, Expect=5e-126]} {Dmel: FBgn0265935, coro, [Score=398, Expect=2e-133]} {Celegans: WBGene00000768, cor-1, Coronin-like protein cor-1, [Score=331, Expect=4e-108]} {Smed: dd_Smed_v6_448_0_1, dd_Smed_v6_448_0_1, [Score=417, Expect=5e-141]} {RNA1509_25447, RNA1509_33208} {RNA1310_10454, RNA1509_25447, RNA1509_33208} {RNA1509_25447, RNA1509_33208, RNA815_11746} |
49. | MligTC455_42806 | 585 | 12.18 | Mlig455_040637 | Neo: - Age: Up-Down-Down |
ANGPTL1 | 0.955 | - | - | 0.955 | - | - | - | Mlig455_040637 {REF} {Length: 821} {TRANSSPLICED} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=106.1]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.0, Expect=2e-22]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=93.6, Expect=6e-24]; ENSG00000229353, TNXB, tenascin XB, [Score=92.4, Expect=1e-21]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=91.7, Expect=1e-21]; ENSG00000168477, TNXB, tenascin XB, [Score=91.3, Expect=3e-21]; ENSG00000231608, TNXB, tenascin XB, [Score=91.3, Expect=3e-21]; ENSG00000233323, TNXB, tenascin XB, [Score=91.3, Expect=3e-21]; ENSG00000206258, TNXB, tenascin XB, [Score=91.3, Expect=3e-21]; ENSG00000236236, TNXB, tenascin XB, [Score=90.9, Expect=3e-21]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=90.1, Expect=2e-21]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=89.7, Expect=8e-21]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=99.8, Expect=1e-24]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=96.7, Expect=1e-23]} {Dmel: FBgn0034160, CG5550, [Score=103, Expect=1e-27]} {Celegans: WBGene00020516, T15B7.1, [Score=63.2, Expect=4e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=99.8, Expect=7e-25]} {RNA1509_14033} {RNA1310_99983, RNA1509_14033} {RNA1509_14033, RNA815_28243} |
50. | MligTC455_29844 | 69 | 1.43 | Mlig455_029033 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_029033 {REF} {Length: 6273} {Pfam: Chromo (CHRromatin Organisation MOdifier) domain [PF00385.26, score=22.8]} {Smed: dd_Smed_v6_9908_0_1, dd_Smed_v6_9908_0_1, [Score=75.9, Expect=5e-16]} {RNA1509_13774} {RNA1310_8972.1} {RNA815_14204} | |
51. | MligTC455_32661 | 38 | 0.78 | Mlig455_068427 | Neo: - Age: - |
0.954 | - | - | 0.954 | - | - | - | Mlig455_068427 {REF} {Length: 5227} {NoTransDecoderORF} {RNA1509_26128} {RNA1310_7005.1} {RNA815_8730.1} | |
52. | MligTC455_51461 | 75 | 1.57 | Mlig455_016885 | Neo: - Age: Down-Up-Down |
0.954 | - | - | - | - | - | 0.954 | Mlig455_016885 {REF} {Length: 4367} {Smed: dd_Smed_v6_9798_0_1, dd_Smed_v6_9798_0_1, [Score=112, Expect=2e-25]} {RNA1509_27160} {RNA1310_5219.1} {RNA815_1908} | |
53. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.953 | - | - | - | - | 0.953 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
54. | MligTC455_41993 | 177 | 3.68 | Mlig455_058555 | Neo: - Age: - |
SLC18A2 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_058555 {REF} {Length: 2488} {Pfam: Major Facilitator Superfamily [PF07690.18, score=160.2]} {Human: ENSG00000165646, SLC18A2, solute carrier family 18 member A2, [RH, Score=505, Expect=4e-173]} {Mouse: ENSMUSG00000025094, Slc18a2, solute carrier family 18 (vesicular monoamine), member 2, [RH, Score=506, Expect=9e-174]} {Dmel: FBgn0260964, Vmat, Vesicular monoamine transporter, [RH, Score=522, Expect=9e-179]} {Celegans: WBGene00000295, cat-1, [RH, Score=478, Expect=1e-162]} {Smed: dd_Smed_v6_16043_0_1, dd_Smed_v6_16043_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_54526} {RNA1310_13917.1} {RNA815_24305} |
55. | MligTC455_46723 | 138 | 2.87 | Mlig455_066171 | Neo: - Age: - |
CHRNA6 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_066171 {REF} {Length: 1617} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=107.0]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=48.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=8e-32]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=123, Expect=2e-30]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=122, Expect=6e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=131, Expect=2e-33]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=130, Expect=2e-33]} {Celegans: WBGene00006765, unc-29, Acetylcholine receptor subunit beta-type unc-29, [Score=92.0, Expect=4e-20]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [Score=142, Expect=2e-37]} {RNA1509_55012} {RNA1310_6313.1} {RNA815_3014.1} |
56. | MligTC455_03296 | 26 | 0.53 | Mlig455_029598, Mlig455_070636 | Neo: - Age: Down-Up-Down |
0.952 | - | - | 0.952 | - | - | - | Mlig455_029598 {REF} {Length: 426} {NoTransDecoderORF} {RNA1509_2858} {RNA1310_73645} {RNA815_38207} Mlig455_070636 {REF} {Length: 135} {NoTransDecoderORF} {RNA1509_2858} {RNA1310_73645} {RNA815_38207} |
|
57. | MligTC455_19582 | 125 | 2.6 | Mlig455_063355 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_063355 {REF} {Length: 2588} {TRANSSPLICED} {Pfam: Coiled-coil domain-containing protein 24 family [PF15669.7, score=98.8]} {Smed: dd_Smed_v6_16835_0_1, dd_Smed_v6_16835_0_1, [Score=105, Expect=3e-27]} {RNA1310_34434} {RNA815_28600} | |
58. | MligTC455_22612 | 109 | 2.26 | Mlig455_026956 | Neo: - Age: - |
FYN | 0.952 | - | - | - | - | 0.952 | - | Mlig455_026956 {REF} {Length: 4578} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=252.5]; Protein kinase domain [PF00069.27, score=163.9]; SH3 domain [PF00018.30, score=35.6]; Variant SH3 domain [PF07653.19, score=34.4]; SH2 domain [PF00017.26, score=33.2]; Variant SH3 domain [PF14604.8, score=30.8]; Bacterial SH3 domain [PF08239.13, score=24.4]; ABC1 atypical kinase-like domain [PF03109.18, score=18.9]; Kinase-like [PF14531.8, score=18.8]} {Human: ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [Score=285, Expect=4e-89]; ENSG00000101336, HCK, HCK proto-oncogene, Src family tyrosine kinase, [Score=275, Expect=6e-86]; ENSG00000182866, LCK, LCK proto-oncogene, Src family tyrosine kinase, [Score=272, Expect=1e-84]} {Mouse: ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [Score=284, Expect=4e-89]; ENSMUSG00000000409, Lck, lymphocyte protein tyrosine kinase, [Score=275, Expect=1e-85]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=270, Expect=1e-83]} {Dmel: FBgn0262733, Src64B, Src oncogene at 64B, [Score=274, Expect=3e-85]} {Celegans: WBGene00005077, src-1, Tyrosine protein-kinase src-1, [Score=284, Expect=6e-90]} {Smed: dd_Smed_v6_3363_0_1, dd_Smed_v6_3363_0_1, [Score=310, Expect=9e-100]} {RNA1509_37079} {RNA1310_14637, RNA1509_37079} {RNA1509_37079, RNA815_4860} |
59. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
60. | MligTC455_53735 | 124 | 2.58 | Mlig455_043944, Mlig455_044023 | Neo: Int S/G2/M Age: Up-Down-Down Region-enriched R2: 4.522/0.00648 |
0.952 | - | - | 0.952 | - | - | - | Mlig455_043944 {REF} {Length: 4237} {RNA1509_45477} {RNA1310_32327} {RNA815_37449} Mlig455_044023 {REF} {Length: 3658} {RNA1509_45477} {RNA1310_32327} {RNA815_32136} |
|
61. | MligTC455_01303 | 33 | 0.68 | Mlig455_052382, Mlig455_062606, Mlig455_064134 | Neo: - Age: - |
0.951 | - | - | 0.951 | - | - | - | Mlig455_052382 {REF} {Length: 238} {NoTransDecoderORF} {RNA1310_24659} {RNA815_41866} Mlig455_062606 {REF} {Length: 505} {NoTransDecoderORF} {RNA1310_24659} {RNA815_41866} Mlig455_064134 {REF} {Length: 625} {NoTransDecoderORF} {RNA1310_24659} {RNA815_41866} |
|
62. | MligTC455_07469 | 44 | 0.92 | Mlig455_053361 | Neo: - Age: Up-Up-Down |
DLX1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_053361 {REF} {Length: 1777} {Pfam: Homeodomain [PF00046.31, score=72.7]} {Human: ENSG00000144355, DLX1, distal-less homeobox 1, [RH, Score=142, Expect=3e-39]} {Mouse: ENSMUSG00000041911, Dlx1, distal-less homeobox 1, [RH, Score=142, Expect=2e-39]; ENSMUSG00000029754, Dlx6, distal-less homeobox 6, [RH, Score=137, Expect=3e-37]} {Dmel: FBgn0000157, Dll, Distal-less, [RH, Score=138, Expect=1e-37]} {Celegans: WBGene00000463, ceh-43, Homeobox protein ceh-43, [RH, Score=102, Expect=6e-25]} {Smed: dd_Smed_v6_19040_0_1, dd_Smed_v6_19040_0_1, [RH, Score=159, Expect=7e-44]} {RNA1509_39701} {RNA1310_24974} {RNA815_26393} |
63. | MligTC455_14087 | 22 | 0.46 | Mlig455_005059 | Neo: - Age: - |
SEC14L4 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_005059 {REF} {Length: 2564} {Pfam: CRAL/TRIO domain [PF00650.22, score=80.6]} {Human: ENSG00000133488, SEC14L4, SEC14 like lipid binding 4, [Score=145, Expect=5e-40]; ENSG00000100003, SEC14L2, SEC14 like lipid binding 2, [Score=140, Expect=7e-38]; ENSG00000214491, SEC14L6, SEC14 like lipid binding 6, [Score=139, Expect=3e-37]} {Mouse: ENSMUSG00000003585, Sec14l2, SEC14-like lipid binding 2, [Score=145, Expect=1e-39]; ENSMUSG00000054986, Sec14l3, SEC14-like lipid binding 3, [Score=142, Expect=2e-38]} {Dmel: FBgn0035146, CG13893, [Score=92.8, Expect=8e-21]} {Celegans: WBGene00011962, T23G5.2, CRAL-TRIO domain-containing protein T23G5.2, [Score=104, Expect=1e-24]} {Smed: dd_Smed_v6_12821_0_1, dd_Smed_v6_12821_0_1, [Score=155, Expect=8e-44]} {RNA1509_29843} {RNA1310_31007} {RNA815_24143} |
64. | MligTC455_16904 | 247 | 5.15 | Mlig455_065887 | Neo: - Age: Up-Down-Up |
0.951 | - | - | - | - | - | 0.951 | Mlig455_065887 {REF} {Length: 1953} {RNA1509_55092} {RNA1310_20395.1} {RNA815_8649} | |
65. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
66. | MligTC455_11162 | 28 | 0.58 | Mlig455_011955 | Neo: - Age: - |
WDR27 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_011955 {REF} {Length: 3573} {TRANSSPLICED} {Pfam: WD domain, G-beta repeat [PF00400.34, score=19.6]} {Human: ENSG00000184465, WDR27, WD repeat domain 27, [RH, Score=85.1, Expect=3e-16]} {Mouse: ENSMUSG00000046991, Wdr27, WD repeat domain 27, [RH, Score=85.9, Expect=1e-16]} {RNA1509_39566} {RNA1310_6747.1, RNA1509_39566} {RNA1509_39566, RNA815_26826} |
67. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
68. | MligTC455_31365 | 164 | 3.42 | Mlig455_063065 | Neo: Irradiation |
DDX27 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_063065 {REF} {Length: 3157} {TRANSSPLICED} {Pfam: DEAD/DEAH box helicase [PF00270.31, score=158.5]; Helicase conserved C-terminal domain [PF00271.33, score=98.5]; Type III restriction enzyme, res subunit [PF04851.17, score=23.2]; Utp25, U3 small nucleolar RNA-associated SSU processome protein 25 [PF06862.14, score=18.0]} {Human: ENSG00000124228, DDX27, DEAD-box helicase 27, [RH, Score=531, Expect=9e-180]} {Mouse: ENSMUSG00000017999, Ddx27, DEAD (Asp-Glu-Ala-Asp) box polypeptide 27, [RH, Score=518, Expect=9e-175]} {Dmel: FBgn0021995, Rs1, [RH, Score=493, Expect=4e-165]} {Celegans: WBGene00022148, ddx-27, DEAD boX helicase homolog, [RH, Score=506, Expect=9e-171]} {Smed: dd_Smed_v6_5413_0_1, dd_Smed_v6_5413_0_1, [RH, Score=468, Expect=8e-158]} {RNA1509_13819} {RNA1310_9851, RNA1509_13819} {RNA1509_13819, RNA815_4333} |
69. | MligTC455_50586 | 162 | 3.38 | Mlig455_052740 | Neo: Int S/G2/M Age: Up-Down-Down |
0.95 | - | - | 0.950 | - | - | - | Mlig455_052740 {REF} {Length: 4917} {TRANSSPLICED} {RNA1509_17849} {RNA1310_8853.1, RNA1509_17849} {RNA1509_17849, RNA815_1759.1} |